Rare diseases
Investigational molecules
Locations
Back to Slovakia38 clinical trials in Lučenec, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)Study on the Effects of T89 and Glyceryl Trinitrate for Patients with Stable Angina
SlovakiaA study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)
SlovakiaStudy of AZD0780 in patients with high cholesterol and heart disease or risk of heart disease to lower bad cholesterol levels
SlovakiaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
SlovakiaStudy of ISIS 678354 for Patients with Severe High Triglycerides
SlovakiaStudy on the Effect of Survodutide on Heart Safety in Patients with Obesity and Cardiovascular or Kidney Disease
SlovakiaStudy on the Effects of Pelacarsen on Heart Disease in Patients with Cardiovascular Conditions
SlovakiaStudy on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels
SlovakiaStudy of Evolocumab to Prevent Heart Disease Events in High-Risk Patients Without Previous Heart Attack or Stroke
SlovakiaStudy on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
SlovakiaStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
SlovakiaStudy on the Effect of Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease Not Adequately Managed by Current Lipid-Lowering Treatments
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on heart failure prevention and innovative treatments for atherosclerotic cardiovascular disease. Research includes evaluation of new compounds for reducing major cardiovascular events and improving patient outcomes.
Multiple trials investigating combination therapies and novel approaches to reduce cardiovascular mortality.
Comprehensive research on Type 2 Diabetes and obesity management, exploring innovative treatments and their impact on cardiovascular outcomes. Studies include evaluation of new compounds for weight management and glycemic control.
Advanced clinical trials testing next-generation therapies for metabolic disorders.
Important studies addressing chronic kidney disease and associated conditions. Research focuses on novel combination therapies to slow disease progression and improve outcomes in patients with kidney disorders.
Innovative approaches to treating kidney disease with combination therapies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
